These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 14731580)

  • 21. Chromosomal alterations associated with the transition from in situ to invasive breast cancer.
    Ellsworth RE; Vertrees A; Love B; Hooke JA; Ellsworth DL; Shriver CD
    Ann Surg Oncol; 2008 Sep; 15(9):2519-25. PubMed ID: 18622645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of androgen receptors and inhibin/activin alpha and betaA subunits in breast apocrine lesions.
    Shim HS; Jung WH; Kim H; Park K; Cho NH
    APMIS; 2006 May; 114(5):352-8. PubMed ID: 16725011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
    Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
    Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.
    Wedrén S; Magnusson C; Humphreys K; Melhus H; Kindmark A; Stiger F; Branting M; Persson I; Baron J; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1775-83. PubMed ID: 17855696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
    Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
    Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen mediation of thrombocytosis in epithelial ovarian cancer biology.
    Li AJ; Karlan BY
    Clin Cancer Res; 2005 Nov; 11(22):8015-8. PubMed ID: 16299230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Length of androgen receptor-CAG repeats in fertile and infertile Egyptian men.
    Badran WA; Fahmy I; Abdel-Megid WM; Elder K; Mansour R; Kent-First M
    J Androl; 2009; 30(4):416-25. PubMed ID: 19168451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Androgen receptor and male infertility].
    Eldar-Geva T; Milatiner D; Halle D
    Harefuah; 2004 Jun; 143(6):432-9, 461. PubMed ID: 15524101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
    Andersson P; Varenhorst E; Söderkvist P
    Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast.
    Emberley ED; Alowami S; Snell L; Murphy LC; Watson PH
    Breast Cancer Res; 2004; 6(4):R308-15. PubMed ID: 15217497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BNIP3 as a progression marker in primary human breast cancer; opposing functions in in situ versus invasive cancer.
    Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):467-74. PubMed ID: 17255267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between androgen receptor CAG repeat length and sperm morphology.
    Milatiner D; Halle D; Huerta M; Margalioth EJ; Cohen Y; Ben-Chetrit A; Gal M; Mimoni T; Eldar-Geva T
    Hum Reprod; 2004 Jun; 19(6):1426-30. PubMed ID: 15117901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeat expansion detection analysis of (CAG)n tracts in tumor cell lines, testicular tumors, and testicular cancer families.
    King BL; Peng HQ; Goss P; Huan S; Bronson D; Kacinski BM; Hogg D
    Cancer Res; 1997 Jan; 57(2):209-14. PubMed ID: 9000556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the lengths of androgen receptor triplet repeats in brain and blood in motor neuron diseases.
    Saunderson RB; Yu B; Trent RJ; Pamphlett R
    J Neurol Sci; 2008 Apr; 267(1-2):125-8. PubMed ID: 17997416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility.
    Ferlin A; Bartoloni L; Rizzo G; Roverato A; Garolla A; Foresta C
    Mol Hum Reprod; 2004 Jun; 10(6):417-21. PubMed ID: 15044606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study of breast cancers detected in the incident round of the UK NHS Breast Screening Programme: the importance of early detection and treatment of ductal carcinoma in situ.
    Maxwell AJ; Hanson IM; Sutton CJ; Fitzgerald J; Pearson JM
    Breast; 2001 Oct; 10(5):392-8. PubMed ID: 14965613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action.
    Ding D; Xu L; Menon M; Reddy GP; Barrack ER
    Prostate; 2005 Feb; 62(2):133-9. PubMed ID: 15389799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.